Delivery Order SPE2DB22D3004-SPE2DB24FQA42

Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566491539 METHYLPHENIDATE ER 36 MG TAB 100S, a prescription drug product, with a completion date of November 20, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,087.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the delivery of 4566736023 ! METHYLPHENIDATE ER 36 MG TAB 100S, with a completion date of December 17, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.41 firm fixed-price delivery order is for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The award has an ultimate completion date of January 30, 2025 and is not designated as a set-aside procurement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,637.01 firm fixed-price delivery order covers the supply of METHYLPHENIDATE ER 36 MG TAB 100S, with a completion date of January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,112.74 firm fixed-price delivery order is for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, with a completion date of November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of METHYLPHENIDATE ER 36 MG TAB 100S. The contract is a Delivery Order valued at $2,351.53 and has a firm fixed price pricing type. The contract has an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $1,584.24, is a Firm Fixed Price Delivery Order for the supply of 4564568108 - METHYLPHENIDATE ER 36 MG TAB 100S. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
This federal contract award, valued at $3,141.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,078.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The contract is not designated as a set-aside and is a firm fixed-price agreement with a completion date of January 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,333.28, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 7, 2024. This award is not...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQA42
    Delivery Order

This federal contract award, valued at $1,192.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564312406 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 7/17/24, 9:54 AM